US Stock MarketDetailed Quotes

LRMR Larimar Therapeutics

Watchlist
  • 3.660
  • -0.130-3.43%
Close Jan 10 16:00 ET
  • 3.590
  • -0.070-1.91%
Post 20:01 ET
233.53MMarket Cap-3.18P/E (TTM)

Larimar Therapeutics Key Stats

Larimar Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Larimar Therapeutics Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Jan 3, 2025

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Price
% Chg

No Data